AKT1 and diabetic foot: Among them, quercetin showed the strongest binding affinity with AKT1, with a minimum binding energy of −10.3 kcal/mol, indicating that this compound–target interaction may play a central role in the pharmacological mechanism of Fespixon cream for diabetic foot ulcer treatment.